Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20929 | 25634387 | Indian Heart J | Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α. | 2014 | Details |
| A20940 | 25627311 | Liver Int | Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects. | 2014 | Details |
| A20957 | 25617860 | Atherosclerosis | A concise review of non-alcoholic fatty liver disease. | 2015 | Details |
| A20981 | 25604802 | Expert Opin Investig Drugs | Early investigational drugs targeting PPAR-α for the treatment of metabolic disease. | 2015 | Details |
| A20983 | 25603326 | Rev Esp Enferm Dig | Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis. | 2015 | Details |
| A20989 | 25600030 | Curr Vasc Pharmacol | Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment. | 2015 | Details |
| A20991 | 25598995 | J Clin Exp Cardiolog | Association between inflammatory markers and liver fat: The Multi-Ethnic Study of Atherosclerosis. | 2022 | Details |
| A20996 | 25595882 | J Hepatol | Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis. | 2015 | Details |
| A21004 | 25583095 | Clin Biochem | Laboratory assessment of cardiometabolic risk in overweight and obese children. | 2015 | Details |
| A21026 | 25566323 | Front Genet | TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease. | 2014 | Details |
| A21034 | 25564638 | BMJ Case Rep | Resolution of NASH with weight loss documented by hepatic MRI. | 2015 | Details |
| A21036 | 25563143 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. | 2015 | Details |
| A21040 | 25561963 | J Tehran Heart Cent | Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature review. | 2014 | Details |
| A21048 | 25556679 | Cell Mol Life Sci | Metabolic insights from zebrafish genetics, physiology, and chemical biology. | 2015 | Details |
| A21057 | 25550397 | Circ Cardiovasc Imaging | Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease. | 2014 | Details |
| A21069 | 27188459 | Nat Rev Dis Primers | Nonalcoholic fatty liver disease. | 2015 | Details |
| A21083 | 25544875 | World J Hepatol | Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. | 2014 | Details |
| A21088 | 25543202 | Alcohol | A comparison of the cardiometabolic profile of black South Africans with suspected non-alcoholic fatty liver disease (NAFLD) and excessive alcohol use. | 2014 | Details |
| A21090 | 25541989 | PLoS One | LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study. | 2014 | Details |
| A21101 | 25536561 | Probl Radiac Med Radiobiol | Structure of comorbid diseases in patients with non-alcoholic fatty liver disease, exposed to ionizing radiation as a result of the Chornobyl NPP accident. | 2014 | Details |
| A21108 | 25533429 | Eur J Gastroenterol Hepatol | Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis. | 2015 | Details |
| A21128 | 25526027 | Oncotarget | Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat. | 2014 | Details |
| A21152 | 25514910 | Rev Recent Clin Trials | Common features of the metabolic syndrome and nonalcoholic fatty liver disease. | 2014 | Details |
| A21155 | 25514907 | Rev Recent Clin Trials | Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection. | 2014 | Details |
| A21165 | 25509904 | Ter Arkh | [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease]. | 2014 | Details |
| A21166 | 25509888 | Ter Arkh | [Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity]. | 2014 | Details |
| A21188 | 25492997 | World J Gastroenterol | Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. | 2014 | Details |
| A21231 | 25468788 | Med Hypotheses | Pentoxifylline in the management of metabolic syndrome and chronic hepatitis C. | 2014 | Details |
| A21240 | 25460293 | Horm Mol Biol Clin Investig | Nutrition: a promising route for prevention and management of obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
| A21241 | 25460228 | Curr Opin Pharmacol | Transgenerational effects of obesogens and the obesity epidemic. | 2014 | Details |
| A21247 | 25456868 | Am J Cardiol | Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk. | 2014 | Details |
| A21248 | 25456789 | Med Hypotheses | Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis? | 2014 | Details |
| A21249 | 25456154 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease is associated with progression of arterial stiffness. | 2014 | Details |
| A21268 | 25445436 | Life Sci | Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice. | 2014 | Details |
| A21270 | 25445395 | J Hepatol | Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. | 2014 | Details |
| A21274 | 25440222 | J Nutr Biochem | Pathophysiological basis for compromised health beyond generations: role of maternal high-fat diet and low-grade chronic inflammation. | 2014 | Details |
| A21282 | 28664097 | Integr Med Res | Practical approaches to the nutritional management of nonalcoholic fatty liver disease. | 2014 | Details |
| A21286 | 25433159 | J Hepatol | The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease. | 2014 | Details |
| A21291 | 25429853 | Aliment Pharmacol Ther | NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels. | 2014 | Details |
| A21297 | 25427048 | J Cardiovasc Med (Hagerstown) | Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? | 2015 | Details |
| A21301 | 25422733 | Iran J Neurol | Association between non-alcoholic fatty liver disease and ischemic stroke. | 2014 | Details |
| A21304 | 25419656 | PLoS One | Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease. | 2014 | Details |
| A21312 | 25413450 | Metab Brain Dis | Low-grade chronic inflammation induces behavioral stereotypy in rats. | 2014 | Details |
| A21340 | 25390016 | Horm Mol Biol Clin Investig | The pathophysiology of abdominal adipose tissue depots in health and disease. | 2014 | Details |
| A21342 | 25389366 | Am J Physiol Endocrinol Metab | CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. | 2014 | Details |
| A21344 | 25386164 | Front Endocrinol (Lausanne) | Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. | 2014 | Details |
| A21359 | 25378958 | Hepat Med | Surgical treatment of nonalcoholic fatty liver disease in severely obese patients. | 2014 | Details |
| A21370 | 25371150 | J Cell Biochem | The hepatic transcriptome of young suckling and aging intrauterine growth restricted male rats. | 2015 | Details |
| A21372 | 25369449 | Radiology | High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. | 2014 | Details |
| A21385 | 25356042 | World J Gastroenterol | Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. | 2014 | Details |
| A21398 | 25349644 | World J Hepatol | Lipid-lowering agents in the management of nonalcoholic fatty liver disease. | 2014 | Details |
| A21415 | 25339806 | World J Gastroenterol | Nonalcoholic fatty liver disease and aging: epidemiology to management. | 2014 | Details |
| A21416 | 25339805 | World J Gastroenterol | Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2014 | Details |
| A21427 | 25327387 | Expert Rev Gastroenterol Hepatol | Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease. | 2014 | Details |
| A21431 | 25324136 | Horm Res Paediatr | Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle. | 2014 | Details |
| A21433 | 25320186 | J Nutr | Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women. | 2014 | Details |
| A21448 | 25311381 | Clin Gastroenterol Hepatol | Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. | 2014 | Details |
| A21450 | 25310404 | PLoS One | The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease. | 2014 | Details |
| A21455 | 25309067 | World J Gastroenterol | Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. | 2014 | Details |
| A21457 | 25307311 | Mini Rev Med Chem | Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome. | 2014 | Details |
| A21464 | 25302781 | Hepatology | Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. | 2015 | Details |
| A21466 | 25300437 | Kidney Blood Press Res | Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients. | 2014 | Details |
| A21480 | 25291138 | J Clin Gastroenterol | Coffee and liver health. | 2015 | Details |
| A21484 | 25285192 | Frontline Gastroenterol | Non-alcoholic fatty liver disease: a practical approach to treatment. | 2014 | Details |
| A21494 | 25278691 | World J Gastroenterol | Non-alcoholic fatty liver disease: what the clinician needs to know. | 2014 | Details |
| A21506 | 25267960 | J Gastrointestin Liver Dis | A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators. | 2014 | Details |
| A21511 | 25266069 | J Diabetes | Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth. | 2014 | Details |
| A21512 | 25265201 | Nanotoxicology | Intratracheal exposure to multi-walled carbon nanotubes induces a nonalcoholic steatohepatitis-like phenotype in C57BL/6J mice. | 2014 | Details |
| A21513 | 25262992 | Eur J Intern Med | Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis. | 2014 | Details |
| A21516 | 25260964 | BMC Gastroenterol | Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease. | 2014 | Details |
| A21527 | 25252298 | Anatol J Cardiol | Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography. | 2014 | Details |
| A21531 | 25251399 | Hepatology | Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. | 2015 | Details |
| A21536 | 25245380 | Curr Med Chem | Association between polycystic ovary syndrome and metabolic syndrome. | 2014 | Details |
| A21541 | 25242225 | Cell Metab | Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. | 2014 | Details |
| A21552 | 25233612 | Adv Clin Chem | Metabolic syndrome in pediatrics. | 2014 | Details |
| A21558 | 25232252 | World J Gastroenterol | Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review. | 2014 | Details |
| A21563 | 25225347 | Adv Nutr | Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. | 2014 | Details |
| A21564 | 25224698 | Dig Liver Dis | The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease. | 2014 | Details |
| A21588 | 25204761 | BMC Med | Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA. | 2014 | Details |
| A21604 | 25193471 | Am J Physiol Heart Circ Physiol | Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease. | 2014 | Details |
| A21613 | 25186086 | Aliment Pharmacol Ther | Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. | 2014 | Details |
| A21624 | 25175670 | J Med Case Rep | Oliguric acute kidney injury as a main symptom of bradycardia and arteriosclerosis resolved by pacemaker implantation: a case report. | 2014 | Details |
| A21626 | 30736212 | Expert Rev Endocrinol Metab | Non-alcoholic fatty liver disease in patients with diabetes mellitus. | 2014 | Details |
| A21631 | 25168159 | Med Sci Monit | Deterioration of heart rate recovery index in patients with non-alcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A21633 | 25165040 | Hepatol Res | Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease. | 2014 | Details |
| A21655 | 25145976 | Hepatol Res | Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications. | 2014 | Details |
| A21659 | 25143715 | Clin Interv Aging | Nonalcoholic fatty liver disease (NAFLD) - a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients. | 2014 | Details |
| A21677 | 25126490 | Springerplus | Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A21681 | 25125077 | Hepatology | Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. | 2015 | Details |
| A21696 | 25111713 | PLoS One | Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis. | 2014 | Details |
| A21698 | 25111123 | Nutrients | Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. | 2014 | Details |
| A21727 | 25088269 | Curr Pediatr Rev | Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us? | 2014 | Details |
| A21732 | 25083925 | Prog Lipid Res | Recent advances in pharmacotherapy for hypertriglyceridemia. | 2014 | Details |
| A21736 | 25083079 | World J Gastroenterol | Nonalcoholic fatty liver disease and the heart in children and adolescents. | 2014 | Details |
| A21739 | 25083076 | World J Gastroenterol | Role of liver biopsy in nonalcoholic fatty liver disease. | 2014 | Details |
| A21759 | 25066109 | Diabetes Metab Res Rev | GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease. | 2014 | Details |
| A21770 | 25059108 | Obes Rev | Metabolically healthy and unhealthy obese--the 2013 Stock Conference report. | 2014 | Details |
| A21779 | 25050550 | PLoS Med | Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. | 2014 | Details |
| A21784 | 29159094 | J Clin Transl Endocrinol | The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A21787 | 25045276 | Clin Exp Gastroenterol | Molecular pathways in non-alcoholic fatty liver disease. | 2014 | Details |